9 participants
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-13
- Start Date:
- 2026-09-01
- Completion:
- 2030-07-19
Conditions
- Acute Myeloid Leukemia
Interventions
- DRUG
- PROCEDURE
No Results Yet